Open Access

[Corrigendum] ND‑09 inhibits chronic myeloid leukemia K562 cell growth by regulating BCR‑ABL signaling

  • Authors:
    • Yan-Hong Liu
    • Man Zhu
    • Pan-Pan Lei
    • Xiao-Yan Pan
    • Wei-Na Ma
  • View Affiliations

  • Published online on: March 3, 2023     https://doi.org/10.3892/or.2023.8518
  • Article Number: 81
  • Copyright : © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

View Figures

Related Articles

Journal Cover

May-2023
Volume 49 Issue 5

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Liu Y, Zhu M, Lei P, Pan X and Ma W: [Corrigendum] ND‑09 inhibits chronic myeloid leukemia K562 cell growth by regulating BCR‑ABL signaling. Oncol Rep 49: 81, 2023.
APA
Liu, Y., Zhu, M., Lei, P., Pan, X., & Ma, W. (2023). [Corrigendum] ND‑09 inhibits chronic myeloid leukemia K562 cell growth by regulating BCR‑ABL signaling. Oncology Reports, 49, 81. https://doi.org/10.3892/or.2023.8518
MLA
Liu, Y., Zhu, M., Lei, P., Pan, X., Ma, W."[Corrigendum] ND‑09 inhibits chronic myeloid leukemia K562 cell growth by regulating BCR‑ABL signaling". Oncology Reports 49.5 (2023): 81.
Chicago
Liu, Y., Zhu, M., Lei, P., Pan, X., Ma, W."[Corrigendum] ND‑09 inhibits chronic myeloid leukemia K562 cell growth by regulating BCR‑ABL signaling". Oncology Reports 49, no. 5 (2023): 81. https://doi.org/10.3892/or.2023.8518